eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2022
vol. 9
 
Share:
Send email
Share:
abstract:
Special paper

Ciclesonide in step-up strategy of asthma treatment. Recommendations of the experts of Polish Society of Allergology

Piotr Kuna
1
,
Ewa Czarnobilska
2
,
Karina Jahnz-Różyk
3
,
Marek Kulus
4
,
Maciej Kupczyk
5
,
Barbara Rogala
6
,
Ziemowit Ziętkowski
7

  1. Klinika Chorób Wewnętrznych, Astmy i Alergii, Uniwersytet Medyczny, Łódź, Polska
  2. Zakład Alergologii Klinicznej i Środowiskowej, Katedra Toksykologii i Chorób Środowiskowych, Uniwersytet Jagielloński Collegium Medicum, Kraków, Polska
  3. Klinika Chorób Wewnętrznych, Pneumonologii, Alergologii i Immunologii Klinicznej, Wojskowy Instytut Medyczny, Warszawa, Polska
  4. Klinika Pneumonologii i Alergologii Wieku Dziecięcego, Warszawski Uniwersytet Medyczny, Warszawa, Polska
  5. Klinika Chorób Wewnętrznych, Astmy i Alergii, Uniwersytecki Szpital Kliniczny im. N. Barlickiego, Łódź, Polska
  6. Klinika Chorób Wewnętrznych, Alergologii i Immunologii Klinicznej, Śląski Uniwersytet Medyczny, Katowice, Polska
  7. Klinika Alergologii i Chorób Wewnętrznych, Wydział Nauk o Zdrowiu, Uniwersytet Medyczny, Białystok, Polska
Alergologia Polska – Polish Journal of Allergology 2022; 9, 2: 63–69
DOI: https://doi.org/10.5114/pja.2022.116240
Online publish date: 2022/05/16
View full text Get citation
 
PlumX metrics:
Asthma is a chronic inflammatory disease of the respiratory tract that significantly worsens the quality of life, the patient’s efficiency and is a burden to the health care system. In the long term, the goals of asthma treatment are to reduce the risk of exacerbations, reduce the number of unscheduled medical appointments and hospitalizations, the use of systemic steroids, and the reduction of respiratory parameters loss. According to the results of clinical trials, the first step in the prevention of severe asthma exacerbations should be the optimal anti-inflammatory treatment with the use of a safe inhaled glucocorticosteroid. Sometimes an increase of the dose of inhaled corticosteroids is required periodically to prevent or treat exacerbations. Oral corticosteroids have many side effects, increase treatment costs and shorten the life of patients with asthma, so we are trying to replace them with topical medications. The document presents the pharmacological profile, clinical efficacy and treatment regimens in the exacerbation of asthma with the use of ciclesonide, which is a safe drug even in high doses and has a quick and strong anti-inflammatory effect, allows to improve the clinical condition and reduce the need for systemic steroid treatment.
keywords:

asthma, asthma exacerbations, anti-inflammatory therapy, ciclesonide


Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.